| アブストラクト | Importance: Adhesion-related complications (ARCs), including small-bowel obstruction, are common complications of intra-abdominal surgery. Statins, which have antifibrotic pleiotropic effects, inhibit adhesion formation in murine models but have not been assessed in humans. Objective: To assess whether statin use at the time of intra-abdominal surgery is associated with a reduction in ARCs. Design, Setting, and Participants: These 2 separate retrospective cohort studies (The Health Improvement Network [THIN] and Optum's Clinformatics Data Mart [Optum]) compared adults receiving statins with those not receiving statins at the time of intra-abdominal surgery. Individuals undergoing intra-abdominal surgery from January 1, 1996, to December 31, 2013, in the United Kingdom and from January 1, 2000, to December 31, 2016, in the US were included in the study. Those with obstructive events before surgery or a history of inflammatory bowel disease were excluded. Data analysis was performed from September 1, 2012, to November 24, 2020. Exposure: The primary exposure was statin use at the time of surgery. Main Outcomes and Measures: The primary outcome was ARCs, defined as small-bowel obstruction or need for adhesiolysis, occurring after surgery. Sensitivity analyses included statin use preceding but not concurrent with surgery, fibrate use, and angiotensin-converting enzyme inhibitor use. All analyses were adjusted for age, sex, and conditions associated with microvascular disease, such as hypertension, hyperlipidemia, obesity, and tobacco use; surgical approach and site; and diagnosis of a malignant tumor. Results: A total of 148601 individuals met the inclusion criteria for THIN (mean [SD] age, 49.6 [17.7] years; 70.1% female) and 1188217 for Optum (mean [SD] age, 48.2 [16.4] years; 72.6% female). A total of 2060 participants (1.4%) experienced an ARC in THIN and 54136 (4.6%) in Optum. Statin use at the time of surgery was associated with decreased risk of ARCs (THIN: adjusted hazard ratio [HR], 0.81; 95% CI, 0.71-0.92; Optum: adjusted HR, 0.92; 95% CI, 0.90-0.95). Similar associations were appreciated between statins and small-bowel obstruction (THIN: adjusted HR, 0.80; 95% CI, 0.70-0.92; Optum: adjusted HR, 0.88; 95% CI, 0.85-0.91). Conclusions and Relevance: This study's findings suggest that, among individuals in 2 separate cohorts undergoing intra-abdominal surgery, statin use may be associated with a reduced risk of postoperative ARCs. Statins may represent an inexpensive, well-tolerated pharmacologic option for preventing ARCs. |
|---|
| 投稿者 | Scott, Frank I; Vajravelu, Ravy K; Mamtani, Ronac; Bianchina, Nicholas; Mahmoud, Najjia; Hou, Jason K; Wu, Qufei; Wang, Xingmei; Haynes, Kevin; Lewis, James D |
|---|
| 組織名 | Division of Gastroenterology and Hepatology, University of Colorado Anschutz;Medical Campus, Aurora.;Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania,;Philadelphia.;Division of Gastroenterology, University of Pennsylvania, Philadelphia.;Abramson Cancer Center, University of Pennsylvania, Philadelphia.;University of Colorado School of Medicine, Aurora.;Department of Surgery, University of Pennsylvania, Philadelphia.;Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey;Veterans Affairs Medical Center, Houston, Texas.;Department of Scientific Affairs, HealthCore Inc, Wilmington, Delaware. |
|---|
